Indivior Pharmaceuticals, Inc. (INDV)
36.18
-0.69
(-1.87%)
USD |
NASDAQ |
Aug 24, 16:00
36.18
0.00 (0.00%)
After-Hours: 20:00
Indivior Pharmaceuticals Total Assets (Quarterly) : 1.233B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.233B |
| March 31, 2026 | 1.197B |
| December 31, 2025 | 1.204B |
| September 30, 2025 | 1.416B |
| June 30, 2025 | 1.452B |
| March 31, 2025 | 1.375B |
| December 31, 2024 | 1.322B |
| September 30, 2024 | 1.464B |
| June 30, 2024 | 1.535B |
| March 31, 2024 | 1.453B |
| December 31, 2023 | 1.954B |
| September 30, 2023 | 1.852B |
| June 30, 2023 | 1.731B |
| March 31, 2023 | 1.755B |
| December 31, 2022 | 1.769B |
| September 30, 2022 | 1.671B |
| June 30, 2022 | 1.72B |
| March 31, 2022 | 1.724B |
| December 31, 2021 | 1.832B |
| September 30, 2021 | 1.700B |
| June 30, 2021 | 1.671B |
| March 31, 2021 | 1.611B |
| December 31, 2020 | 1.531B |
| Date | Value |
|---|---|
| September 30, 2020 | 1.547B |
| June 30, 2020 | 1.551B |
| March 31, 2020 | 1.512B |
| December 31, 2019 | 1.652B |
| September 30, 2019 | 1.590B |
| June 30, 2019 | 1.568B |
| March 31, 2019 | 1.605B |
| December 31, 2018 | 1.547B |
| September 30, 2018 | 1.555B |
| June 30, 2018 | 1.582B |
| March 31, 2018 | 1.499B |
| December 31, 2017 | 1.444B |
| September 30, 2017 | 1.367B |
| June 30, 2017 | 1.329B |
| March 31, 2017 | 1.225B |
| December 31, 2016 | 1.209B |
| September 30, 2016 | 1.089B |
| June 30, 2016 | 1.073B |
| March 31, 2016 | 1.023B |
| December 31, 2015 | 937.00M |
| September 30, 2015 | 978.00M |
| June 30, 2015 | 958.00M |
| March 31, 2015 | 854.00M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | 1.428B |
| Liquidia Corp. | 521.92M |
| Corcept Therapeutics, Inc. | 888.70M |
| Amneal Pharmaceuticals, Inc. | 3.776B |
| Prestige Consumer Healthcare, Inc. | 4.569B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.441B |
| Shareholders Equity (Quarterly) | -208.00M |
| Debt to Equity Ratio | -2.447 |
| Current Ratio | 0.8353 |
| Net Debt Paydown Yield | -0.57% |